Skip to main content
OpenTrials

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Monoclonal Gammopathy of Undetermined Significance trial results

Completed

Ilaris® Effects in Schnitzler Syndrome (ILESCH)

NCT01390350

Conditions
Immune System Diseases, Immunoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, +2 more
Locations
  • Allergie-Centrum-Charité, Charité University Berlin, Germany
  • Dept. of Dermatology, Klinikum Darmstadt Darmstadt, Germany
  • Dept. of Dermatology, University Heidelberg Heidelberg, Germany
  • Dept. of Dermatology, University Münster Münster, Germany
View Trial Details
Completed

Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors

NCT00933296

Conditions
Immune System Diseases, Immunoproliferative Disorders, Monoclonal Gammopathy of Undetermined Significance, +2 more
Locations
  • CHU de Besançon Service de Dermatologie Besançon, France
  • Service de DermatologieCHU Morvan5 avenue Foch Brest, France
  • Centre Hospitalier Général Bd Yves du Manoir Dax, France
  • Service de Rhumatologie Centre Hospitalier du Mans Le Mans, France
View all 17 locations
View Trial Details

Related conditions